#begin document (nw/wsj/23/wsj_2382); part 000
nw/wsj/23/wsj_2382   0    0               Food   NNP  (TOP(S(NP(NML(NML(NML*               -    -    -   -      (ORG*   (ARG0*            *        *   (3|(6
nw/wsj/23/wsj_2382   0    1                and    CC                       *               -    -    -   -          *        *            *        *       -
nw/wsj/23/wsj_2382   0    2               Drug   NNP                       *)              -    -    -   -          *        *            *        *       -
nw/wsj/23/wsj_2382   0    3     Administration   NNP                       *)              -    -    -   -          *)       *            *        *       3)
nw/wsj/23/wsj_2382   0    4          spokesman    NN                       *)              -    -    -   -          *        *            *        *       -
nw/wsj/23/wsj_2382   0    5               Jeff   NNP                       *               -    -    -   -   (PERSON*        *            *        *       -
nw/wsj/23/wsj_2382   0    6             Nesbit   NNP                       *)              -    -    -   -          *)       *)           *        *       6)
nw/wsj/23/wsj_2382   0    7               said   VBD                    (VP*              say  01    1   -          *      (V*)           *        *       -
nw/wsj/23/wsj_2382   0    8                the    DT             (SBAR(S(NP*               -    -    -   -          *   (ARG1*       (ARG0*        *      (3
nw/wsj/23/wsj_2382   0    9             agency    NN                       *)          agency   -    1   -          *        *            *)       *       3)
nw/wsj/23/wsj_2382   0   10                has   VBZ                    (VP*               -    -    -   -          *        *            *        *       -
nw/wsj/23/wsj_2382   0   11             turned   VBN                    (VP*             turn  12   11   -          *        *          (V*)       *       -
nw/wsj/23/wsj_2382   0   12               over    RP                   (PRT*)              -    -    -   -          *        *            *        *       -
nw/wsj/23/wsj_2382   0   13           evidence    NN                    (NP*)        evidence   -    3   -          *        *       (ARG1*)       *       -
nw/wsj/23/wsj_2382   0   14                 in    IN                    (PP*               -    -    -   -          *        *   (ARGM-LOC*        *       -
nw/wsj/23/wsj_2382   0   15                  a    DT                 (NP(NP*               -    -    -   -          *        *            *   (ARG0*       -
nw/wsj/23/wsj_2382   0   16           criminal    JJ                       *               -    -    -   -          *        *            *        *       -
nw/wsj/23/wsj_2382   0   17      investigation    NN                       *)   investigation   -    1   -          *        *            *        *)      -
nw/wsj/23/wsj_2382   0   18         concerning   VBG                    (VP*          concern  02    1   -          *        *            *      (V*)      -
nw/wsj/23/wsj_2382   0   19           Vitarine   NNP                    (NP*               -    -    -   -      (ORG*        *            *   (ARG1*      (0
nw/wsj/23/wsj_2382   0   20    Pharmaceuticals   NNP                       *               -    -    -   -          *        *            *        *       -
nw/wsj/23/wsj_2382   0   21               Inc.   NNP                    *))))              -    -    -   -          *)       *            *)       *)      0)
nw/wsj/23/wsj_2382   0   22                 to    IN                    (PP*               -    -    -   -          *        *       (ARG2*        *       -
nw/wsj/23/wsj_2382   0   23                the    DT              (NP(NP(NP*               -    -    -   -          *        *            *        *       -
nw/wsj/23/wsj_2382   0   24               U.S.   NNP                       *               -    -    -   -       (GPE)       *            *        *       -
nw/wsj/23/wsj_2382   0   25           Attorney   NNP                       *               -    -    -   -          *        *            *        *       -
nw/wsj/23/wsj_2382   0   26                 's   POS                       *)              -    -    -   -          *        *            *        *       -
nw/wsj/23/wsj_2382   0   27             office    NN                       *)          office   -    5   -          *        *            *        *       -
nw/wsj/23/wsj_2382   0   28                 in    IN                    (PP*               -    -    -   -          *        *            *        *       -
nw/wsj/23/wsj_2382   0   29          Baltimore   NNP            (NP*)))))))))              -    -    -   -       (GPE)       *)           *)       *       -
nw/wsj/23/wsj_2382   0   30                  .     .                      *))              -    -    -   -          *        *            *        *       -

nw/wsj/23/wsj_2382   0    0        Neither    DT  (TOP(S(NP*          -    -   -   -       *   (ARG1*     -
nw/wsj/23/wsj_2382   0    1       Vitarine   NNP        (NP*)         -    -   -   -    (ORG)       *    (0)
nw/wsj/23/wsj_2382   0    2            nor    CC           *          -    -   -   -       *        *     -
nw/wsj/23/wsj_2382   0    3            any    DT     (NP(NP*)         -    -   -   -       *        *     -
nw/wsj/23/wsj_2382   0    4             of    IN        (PP*          -    -   -   -       *        *     -
nw/wsj/23/wsj_2382   0    5            the    DT     (NP(NP*          -    -   -   -       *        *    (3
nw/wsj/23/wsj_2382   0    6    Springfield   NNP   (NML(NML*          -    -   -   -   (GPE*        *     -
nw/wsj/23/wsj_2382   0    7        Gardens   NNP           *)         -    -   -   -       *)       *     -
nw/wsj/23/wsj_2382   0    8              ,     ,           *          -    -   -   -       *        *     -
nw/wsj/23/wsj_2382   0    9           N.Y.   NNP       (NML*)         -    -   -   -    (GPE)       *     -
nw/wsj/23/wsj_2382   0   10              ,     ,           *)         -    -   -   -       *        *     -
nw/wsj/23/wsj_2382   0   11        company    NN           *     company   -   1   -       *        *     -
nw/wsj/23/wsj_2382   0   12             's   POS           *)         -    -   -   -       *        *     3)
nw/wsj/23/wsj_2382   0   13      officials   NNS           *    official   -   1   -       *        *     -
nw/wsj/23/wsj_2382   0   14             or    CC           *          -    -   -   -       *        *     -
nw/wsj/23/wsj_2382   0   15      employees   NNS        *))))         -    -   -   -       *        *)    -
nw/wsj/23/wsj_2382   0   16           have   VBP        (VP*          -    -   -   -       *        *     -
nw/wsj/23/wsj_2382   0   17           been   VBN        (VP*          -    -   -   -       *        *     -
nw/wsj/23/wsj_2382   0   18        charged   VBN        (VP*      charge  05   3   -       *      (V*)    -
nw/wsj/23/wsj_2382   0   19           with    IN        (PP*          -    -   -   -       *   (ARG2*     -
nw/wsj/23/wsj_2382   0   20            any    DT        (NP*          -    -   -   -       *        *     -
nw/wsj/23/wsj_2382   0   21         crimes   NNS       *)))))      crime   -   1   -       *        *)    -
nw/wsj/23/wsj_2382   0   22              .     .          *))         -    -   -   -       *        *     -

nw/wsj/23/wsj_2382   0    0        Vitarine    NNP   (TOP(S(NP*)            -    -   -   -    (ORG)   (ARG0*)       *    (ARG0*)   (ARG0*)           *       (0)
nw/wsj/23/wsj_2382   0    1             won    VBD      (VP(VP*            win  01   2   -       *       (V*)       *         *         *            *        -
nw/wsj/23/wsj_2382   0    2        approval     NN         (NP*       approval  01   1   -       *    (ARG1*      (V*)        *         *            *        -
nw/wsj/23/wsj_2382   0    3              to     TO       (S(VP*             -    -   -   -       *         *   (ARG1*         *         *            *        -
nw/wsj/23/wsj_2382   0    4          market     VB         (VP*         market  01   1   -       *         *        *       (V*)        *            *        -
nw/wsj/23/wsj_2382   0    5               a     DT      (NP(NP*             -    -   -   -       *         *        *    (ARG1*         *            *        -
nw/wsj/23/wsj_2382   0    6         version     NN            *)       version   -   2   -       *         *        *         *         *            *        -
nw/wsj/23/wsj_2382   0    7              of     IN         (PP*             -    -   -   -       *         *        *         *         *            *        -
nw/wsj/23/wsj_2382   0    8               a     DT         (NP*             -    -   -   -       *         *        *         *         *            *        -
nw/wsj/23/wsj_2382   0    9           blood     NN        (NML*             -    -   -   -       *         *        *         *         *            *        -
nw/wsj/23/wsj_2382   0   10        pressure     NN            *)      pressure   -   1   -       *         *        *         *         *            *        -
nw/wsj/23/wsj_2382   0   11        medicine     NN     *))))))))      medicine   -   1   -       *         *)       *)        *)        *            *        -
nw/wsj/23/wsj_2382   0   12             but     CC            *             -    -   -   -       *         *        *         *         *            *        -
nw/wsj/23/wsj_2382   0   13    acknowledged    VBD         (VP*    acknowledge  01   1   -       *         *        *         *       (V*)           *        -
nw/wsj/23/wsj_2382   0   14            that     IN       (SBAR*             -    -   -   -       *         *        *         *    (ARG1*            *        -
nw/wsj/23/wsj_2382   0   15              it    PRP       (S(NP*)            -    -   -   -       *         *        *         *         *       (ARG0*)      (0)
nw/wsj/23/wsj_2382   0   16     substituted    VBD         (VP*     substitute  01   1   -       *         *        *         *         *          (V*)       -
nw/wsj/23/wsj_2382   0   17               a     DT      (NP(NP*             -    -   -   -       *         *        *         *         *       (ARG1*       (2
nw/wsj/23/wsj_2382   0   18      SmithKline    NNP        (NML*             -    -   -   -   (ORG*         *        *         *         *            *        -
nw/wsj/23/wsj_2382   0   19         Beecham    NNP            *             -    -   -   -       *         *        *         *         *            *        -
nw/wsj/23/wsj_2382   0   20             PLC    NNP            *)            -    -   -   -       *)        *        *         *         *            *        -
nw/wsj/23/wsj_2382   0   21         product     NN           *))       product   -   1   -       *         *        *         *         *            *)       2)
nw/wsj/23/wsj_2382   0   22              as     IN         (PP*             -    -   -   -       *         *        *         *         *       (ARG3*        -
nw/wsj/23/wsj_2382   0   23             its   PRP$         (NP*             -    -   -   -       *         *        *         *         *            *    (4|(0)
nw/wsj/23/wsj_2382   0   24             own     JJ           *))            -    -   -   -       *         *        *         *         *            *)       4)
nw/wsj/23/wsj_2382   0   25              in     IN         (PP*             -    -   -   -       *         *        *         *         *   (ARGM-LOC*        -
nw/wsj/23/wsj_2382   0   26           tests    NNS   (NP*)))))))          test   -   1   -       *         *        *         *         *)           *)      (7)
nw/wsj/23/wsj_2382   0   27               .      .           *))            -    -   -   -       *         *        *         *         *            *        -

nw/wsj/23/wsj_2382   0    0               Mr.    NNP   (TOP(S(NP*        -    -   -   -          *        (ARG0*        *            *       (6
nw/wsj/23/wsj_2382   0    1            Nesbit    NNP            *)       -    -   -   -    (PERSON)            *)       *            *        6)
nw/wsj/23/wsj_2382   0    2              also     RB       (ADVP*)       -    -   -   -          *    (ARGM-DIS*)       *            *        -
nw/wsj/23/wsj_2382   0    3              said    VBD         (VP*       say  01   1   -          *           (V*)       *            *        -
nw/wsj/23/wsj_2382   0    4               the     DT  (SBAR(S(NP*        -    -   -   -          *        (ARG1*   (ARG0*            *       (3
nw/wsj/23/wsj_2382   0    5               FDA    NNP            *)       -    -   -   -       (ORG)            *        *)           *        3)
nw/wsj/23/wsj_2382   0    6               has    VBZ         (VP*        -    -   -   -          *             *        *            *        -
nw/wsj/23/wsj_2382   0    7             asked    VBN         (VP*       ask  02   2   -          *             *      (V*)           *        -
nw/wsj/23/wsj_2382   0    8             Bolar    NNP         (NP*        -    -   -   -      (ORG*             *   (ARG2*       (ARG0*       (1
nw/wsj/23/wsj_2382   0    9    Pharmaceutical    NNP            *        -    -   -   -          *             *        *            *        -
nw/wsj/23/wsj_2382   0   10               Co.    NNP            *)       -    -   -   -          *)            *        *)           *)       1)
nw/wsj/23/wsj_2382   0   11                to     TO       (S(VP*        -    -   -   -          *             *   (ARG1*            *        -
nw/wsj/23/wsj_2382   0   12            recall     VB         (VP*    recall  01   2   -          *             *        *          (V*)      (8)
nw/wsj/23/wsj_2382   0   13                at     IN         (PP*        -    -   -   -          *             *        *   (ARGM-LOC*        -
nw/wsj/23/wsj_2382   0   14               the     DT         (NP*        -    -   -   -          *             *        *            *        -
nw/wsj/23/wsj_2382   0   15            retail     JJ            *        -    -   -   -          *             *        *            *        -
nw/wsj/23/wsj_2382   0   16             level     NN           *))    level   -   2   -          *             *        *            *)       -
nw/wsj/23/wsj_2382   0   17               its   PRP$         (NP*        -    -   -   -          *             *        *       (ARG1*    (4|(1)
nw/wsj/23/wsj_2382   0   18           urinary     JJ        (NML*        -    -   -   -          *             *        *            *        -
nw/wsj/23/wsj_2382   0   19             tract     NN            *)    tract   -   2   -          *             *        *            *        -
nw/wsj/23/wsj_2382   0   20        antibiotic     NN    *)))))))))       -    -   -   -          *             *)       *)           *)       4)
nw/wsj/23/wsj_2382   0   21                 .      .           *))       -    -   -   -          *             *        *            *        -

nw/wsj/23/wsj_2382   0    0          But    CC  (TOP(S(S*         -    -   -   -   *             *      *   (ARG1*    -
nw/wsj/23/wsj_2382   0    1           so    RB     (ADVP*         -    -   -   -   *    (ARGM-TMP*      *        *    -
nw/wsj/23/wsj_2382   0    2          far    RB          *)        -    -   -   -   *             *)     *        *    -
nw/wsj/23/wsj_2382   0    3          the    DT       (NP*         -    -   -   -   *        (ARG0*      *        *   (1
nw/wsj/23/wsj_2382   0    4      company    NN          *)   company   -   1   -   *             *)     *        *    1)
nw/wsj/23/wsj_2382   0    5          has   VBZ       (VP*         -    -   -   -   *             *      *        *    -
nw/wsj/23/wsj_2382   0    6          n't    RB          *         -    -   -   -   *    (ARGM-NEG*)     *        *    -
nw/wsj/23/wsj_2382   0    7     complied   VBN       (VP*     comply  01   1   -   *           (V*)     *        *    -
nw/wsj/23/wsj_2382   0    8         with    IN       (PP*         -    -   -   -   *        (ARG1*      *        *    -
nw/wsj/23/wsj_2382   0    9         that    DT       (NP*         -    -   -   -   *             *      *        *   (8
nw/wsj/23/wsj_2382   0   10      request    NN      *)))))   request  01   1   -   *             *)   (V*)       *)   8)
nw/wsj/23/wsj_2382   0   11            ,     ,          *         -    -   -   -   *             *      *        *    -
nw/wsj/23/wsj_2382   0   12          the    DT       (NP*         -    -   -   -   *             *      *   (ARG0*   (6
nw/wsj/23/wsj_2382   0   13    spokesman    NN          *)        -    -   -   -   *             *      *        *)   6)
nw/wsj/23/wsj_2382   0   14         said   VBD       (VP*)       say  01   1   -   *             *      *      (V*)   -
nw/wsj/23/wsj_2382   0   15            .     .         *))        -    -   -   -   *             *      *        *    -

nw/wsj/23/wsj_2382   0    0            Bolar    NNP   (TOP(S(S(NP(NP*)              -    -   -   -         (ORG)       (ARG0*     (ARG0*   (ARG1*          (1
nw/wsj/23/wsj_2382   0    1                ,      ,                 *               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0    2              the     DT           (NP(NP*               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0    3          subject     NN                 *)         subject   -   1   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0    4               of     IN              (PP*               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0    5                a     DT           (NP(NP*               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0    6         criminal     JJ                 *               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0    7    investigation     NN                 *)   investigation   -   1   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0    8               by     IN              (PP*               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0    9              the     DT           (NP(NP*               -    -   -   -            *             *          *        *          (3
nw/wsj/23/wsj_2382   0   10              FDA    NNP                 *)              -    -   -   -         (ORG)            *          *        *           3)
nw/wsj/23/wsj_2382   0   11              and     CC                 *               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   12              the     DT        (NP(NP(NP*               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   13        Inspector    NNP                 *               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   14          General    NNP                 *               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   15               's    POS                 *)              -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   16           office     NN                 *)          office   -   5   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   17               of     IN              (PP*               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   18              the     DT              (NP*               -    -   -   -        (ORG*             *          *        *           -
nw/wsj/23/wsj_2382   0   19           Health    NNP         (NML(NML*)              -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   20              and     CC                 *               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   21            Human    NNP             (NML*               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   22         Services    NNP                *))              -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   23       Department    NNP          *))))))))              -    -   -   -            *)            *          *        *           -
nw/wsj/23/wsj_2382   0   24                ,      ,                 *)              -    -   -   -            *             *)         *)       *           1)
nw/wsj/23/wsj_2382   0   25             only     RB            (ADVP*)              -    -   -   -            *    (ARGM-ADV*)         *        *           -
nw/wsj/23/wsj_2382   0   26           agreed    VBD              (VP*            agree  01   3   -            *           (V*)         *        *           -
nw/wsj/23/wsj_2382   0   27               to     TO            (S(VP*               -    -   -   -            *        (ARG1*          *        *           -
nw/wsj/23/wsj_2382   0   28           recall     VB              (VP*           recall  01   2   -            *             *        (V*)       *           -
nw/wsj/23/wsj_2382   0   29              two     CD           (NP(NP*               -    -   -   -    (CARDINAL)            *     (ARG1*        *          (5
nw/wsj/23/wsj_2382   0   30        strengths    NNS                 *)        strength   -   6   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   31               of     IN              (PP*               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   32              its   PRP$           (NP(NP*               -    -   -   -            *             *          *        *       (4|(1)
nw/wsj/23/wsj_2382   0   33          version     NN                 *)         version   -   2   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   34               of     IN              (PP*               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   35      Macrodantin    NNP          (NP*)))))              -    -   -   -     (PRODUCT)            *          *)       *    (2)|5)|4)
nw/wsj/23/wsj_2382   0   36               ``     ``                 *               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   37               as     RB       (ADVP(ADVP*               -    -   -   -            *             *   (C-ARG1*        *           -
nw/wsj/23/wsj_2382   0   38              far     RB                 *               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   39             down     RB                 *)              -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   40               as     IN              (PP*               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   41           direct     JJ           (NP(NP*               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   42        customers    NNS                 *)              -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   43                ,      ,                 *               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   44           mostly     RB                 *               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   45      wholesalers    NNS      (NP*)))))))))              -    -   -   -            *             *)         *)       *)          -
nw/wsj/23/wsj_2382   0   46                ,      ,                 *               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   47               ''     ''                 *               -    -   -   -            *             *          *        *           -
nw/wsj/23/wsj_2382   0   48              Mr.    NNP              (NP*               -    -   -   -            *             *          *   (ARG0*          (6
nw/wsj/23/wsj_2382   0   49           Nesbit    NNP                 *)              -    -   -   -      (PERSON)            *          *        *)          6)
nw/wsj/23/wsj_2382   0   50             said    VBD              (VP*)             say  01   1   -            *             *          *      (V*)          -
nw/wsj/23/wsj_2382   0   51                .      .                *))              -    -   -   -            *             *          *        *           -

nw/wsj/23/wsj_2382   0    0        Bolar    NNP   (TOP(S(NP(NP*)        -    -   -   -         (ORG)       (ARG0*             *      (1
nw/wsj/23/wsj_2382   0    1            ,      ,               *         -    -   -   -            *             *             *       -
nw/wsj/23/wsj_2382   0    2           of     IN            (PP*         -    -   -   -            *             *             *       -
nw/wsj/23/wsj_2382   0    3     Copiague    NNP         (NP(NP*)        -    -   -   -         (GPE)            *             *       -
nw/wsj/23/wsj_2382   0    4            ,      ,               *         -    -   -   -            *             *             *       -
nw/wsj/23/wsj_2382   0    5         N.Y.    NNP            (NP*)        -    -   -   -         (GPE)            *             *       -
nw/wsj/23/wsj_2382   0    6            ,      ,             *)))        -    -   -   -            *             *)            *       1)
nw/wsj/23/wsj_2382   0    7      earlier    RBR          (ADVP*)        -    -   -   -            *    (ARGM-TMP*)            *       -
nw/wsj/23/wsj_2382   0    8        began    VBD            (VP*      begin  01   2   -            *           (V*)            *       -
nw/wsj/23/wsj_2382   0    9            a     DT         (NP(NP*         -    -   -   -            *        (ARG1*             *       -
nw/wsj/23/wsj_2382   0   10    voluntary     JJ               *         -    -   -   -            *             *    (ARGM-MNR*)      -
nw/wsj/23/wsj_2382   0   11       recall     NN               *)    recall  01   1   -            *             *           (V*)      -
nw/wsj/23/wsj_2382   0   12           of     IN            (PP*         -    -   -   -            *             *        (ARG1*       -
nw/wsj/23/wsj_2382   0   13         both     DT         (NP(NP*         -    -   -   -            *             *             *      (5
nw/wsj/23/wsj_2382   0   14          its   PRP$               *         -    -   -   -            *             *             *      (1)
nw/wsj/23/wsj_2382   0   15         100      CD       (NML(NML*         -    -   -   -   (QUANTITY*             *             *       -
nw/wsj/23/wsj_2382   0   16    milligram     NN               *)        -    -   -   -            *)            *             *       -
nw/wsj/23/wsj_2382   0   17          and     CC               *         -    -   -   -            *             *             *       -
nw/wsj/23/wsj_2382   0   18          50      CD           (NML*         -    -   -   -   (QUANTITY*             *             *       -
nw/wsj/23/wsj_2382   0   19    milligram     NN              *))        -    -   -   -            *)            *             *       -
nw/wsj/23/wsj_2382   0   20     versions    NNS               *)   version   -   2   -            *             *             *       -
nw/wsj/23/wsj_2382   0   21           of     IN            (PP*         -    -   -   -            *             *             *       -
nw/wsj/23/wsj_2382   0   22          the     DT            (NP*         -    -   -   -            *             *             *      (2
nw/wsj/23/wsj_2382   0   23         drug     NN          *))))))      drug   -   1   -            *             *)            *)   5)|2)
nw/wsj/23/wsj_2382   0   24            .      .              *))        -    -   -   -            *             *             *       -

nw/wsj/23/wsj_2382   0    0            The     DT               (TOP(S(NP*            -    -   -   -           *          *         *            *         *         *       (3
nw/wsj/23/wsj_2382   0    1            FDA    NNP                        *)           -    -   -   -        (ORG)         *         *            *         *         *        3)
nw/wsj/23/wsj_2382   0    2            has    VBZ                     (VP*            -    -   -   -           *          *         *            *         *         *        -
nw/wsj/23/wsj_2382   0    3           said    VBD                     (VP*            -    -   -   -           *          *         *            *         *         *        -
nw/wsj/23/wsj_2382   0    4             it    PRP              (SBAR(S(NP*)           -    -   -   -           *     (ARG0*)        *            *         *         *       (3)
nw/wsj/23/wsj_2382   0    5      presented    VBD                     (VP*       present  01   2   -           *        (V*)        *            *         *         *        -
nw/wsj/23/wsj_2382   0    6       evidence     NN                  (NP(NP*)     evidence   -   1   -           *     (ARG1*    (ARG1*)           *         *         *        -
nw/wsj/23/wsj_2382   0    7             it    PRP              (SBAR(S(NP*)           -    -   -   -           *          *    (ARG0*)           *         *         *       (3)
nw/wsj/23/wsj_2382   0    8      uncovered    VBD                  (VP*))))      uncover  01   1   -           *          *)      (V*)           *         *         *        -
nw/wsj/23/wsj_2382   0    9             to     IN                     (PP*            -    -   -   -           *     (ARG2*         *            *         *         *        -
nw/wsj/23/wsj_2382   0   10            the     DT                     (NP*            -    -   -   -           *          *         *            *         *         *       (1
nw/wsj/23/wsj_2382   0   11        company     NN                       *))      company   -   1   -           *          *)        *            *         *         *        1)
nw/wsj/23/wsj_2382   0   12     indicating    VBG                     (VP*            -    -   -   -           *   (C-ARG1*         *            *         *         *        -
nw/wsj/23/wsj_2382   0   13           that     IN                   (SBAR*            -    -   -   -           *          *         *            *         *         *        -
nw/wsj/23/wsj_2382   0   14          Bolar    NNP                   (S(NP*)           -    -   -   -        (ORG)         *         *       (ARG0*)   (ARG0*)   (ARG0*)      (1)
nw/wsj/23/wsj_2382   0   15    substituted    VBD                     (VP*    substitute  01   1   -           *          *         *          (V*)        *         *        -
nw/wsj/23/wsj_2382   0   16            the     DT                     (NP*            -    -   -   -           *          *         *       (ARG1*         *         *       (2
nw/wsj/23/wsj_2382   0   17          brand     NN                    (NML*            -    -   -   -           *          *         *            *         *         *        -
nw/wsj/23/wsj_2382   0   18             -    HYPH                        *            -    -   -   -           *          *         *            *         *         *        -
nw/wsj/23/wsj_2382   0   19           name     NN                        *)           -    -   -   -           *          *         *            *         *         *        -
nw/wsj/23/wsj_2382   0   20        product     NN                        *)      product   -   1   -           *          *         *            *)        *         *        2)
nw/wsj/23/wsj_2382   0   21            for     IN                     (PP*            -    -   -   -           *          *         *       (ARG3*         *         *        -
nw/wsj/23/wsj_2382   0   22            its   PRP$                     (NP*            -    -   -   -           *          *         *            *         *         *    (4|(1)
nw/wsj/23/wsj_2382   0   23            own     JJ                       *))           -    -   -   -           *          *         *            *)        *         *        4)
nw/wsj/23/wsj_2382   0   24             to     TO                   (S(VP*            -    -   -   -           *          *         *   (ARGM-PNC*         *         *        -
nw/wsj/23/wsj_2382   0   25           gain     VB                     (VP*          gain  02   1   -           *          *         *            *       (V*)        *        -
nw/wsj/23/wsj_2382   0   26     government     NN                     (NP*            -    -   -   -           *          *         *            *    (ARG1*         *        -
nw/wsj/23/wsj_2382   0   27       approval     NN                        *            -    -   -   -           *          *         *            *         *         *        -
nw/wsj/23/wsj_2382   0   28             to     TO                   (S(VP*            -    -   -   -           *          *         *            *         *         *        -
nw/wsj/23/wsj_2382   0   29           sell     VB                     (VP*          sell  01   1   -           *          *         *            *         *       (V*)       -
nw/wsj/23/wsj_2382   0   30        generic     JJ                  (NP(NP*            -    -   -   -           *          *         *            *         *    (ARG1*        -
nw/wsj/23/wsj_2382   0   31       versions    NNS                        *)      version   -   2   -           *          *         *            *         *         *        -
nw/wsj/23/wsj_2382   0   32             of     IN                     (PP*            -    -   -   -           *          *         *            *         *         *        -
nw/wsj/23/wsj_2382   0   33    Macrodantin    NNP   (NP*)))))))))))))))))))           -    -   -   -    (PRODUCT)         *)        *            *)        *)        *)      (2)
nw/wsj/23/wsj_2382   0   34              .      .                       *))           -    -   -   -           *          *         *            *         *         *        -

nw/wsj/23/wsj_2382   0    0       Bolar    NNP   (TOP(S(NP*)        -    -   -   -    (ORG)   (ARG0*)           *       (1)
nw/wsj/23/wsj_2382   0    1         has    VBZ         (VP*         -    -   -   -       *         *            *        -
nw/wsj/23/wsj_2382   0    2      denied    VBN         (VP*       deny  01   1   -       *       (V*)           *        -
nw/wsj/23/wsj_2382   0    3        that     IN       (SBAR*         -    -   -   -       *    (ARG1*            *        -
nw/wsj/23/wsj_2382   0    4          it    PRP       (S(NP*)        -    -   -   -       *         *       (ARG0*)      (1)
nw/wsj/23/wsj_2382   0    5    switched    VBD         (VP*     switch  01   2   -       *         *          (V*)       -
nw/wsj/23/wsj_2382   0    6         the     DT         (NP*         -    -   -   -       *         *       (ARG1*       (2
nw/wsj/23/wsj_2382   0    7       brand     NN        (NML*         -    -   -   -       *         *            *        -
nw/wsj/23/wsj_2382   0    8          -    HYPH            *         -    -   -   -       *         *            *        -
nw/wsj/23/wsj_2382   0    9        name     NN            *)        -    -   -   -       *         *            *        -
nw/wsj/23/wsj_2382   0   10     product     NN            *)   product   -   1   -       *         *            *)       2)
nw/wsj/23/wsj_2382   0   11         for     IN         (PP*         -    -   -   -       *         *       (ARG2*        -
nw/wsj/23/wsj_2382   0   12         its   PRP$         (NP*         -    -   -   -       *         *            *    (4|(1)
nw/wsj/23/wsj_2382   0   13         own     JJ           *))        -    -   -   -       *         *            *)       4)
nw/wsj/23/wsj_2382   0   14          in     IN         (PP*         -    -   -   -       *         *   (ARGM-LOC*        -
nw/wsj/23/wsj_2382   0   15        such     JJ         (NP*         -    -   -   -       *         *            *       (7
nw/wsj/23/wsj_2382   0   16     testing     NN      *)))))))      test   -   1   -       *         *)           *)       7)
nw/wsj/23/wsj_2382   0   17           .      .           *))        -    -   -   -       *         *            *        -

#end document
